Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2006; 12(31): 4959-4965
Published online Aug 21, 2006. doi: 10.3748/wjg.v12.i31.4959
Published online Aug 21, 2006. doi: 10.3748/wjg.v12.i31.4959
Table 1 Comparison of clinicopathological data between EBV positive and EBV negative gastric carcinomas
| EBV positive gastric carcinomas (n = 25) | EBV negative gastric carcinomas (n = 103) | P value | |
| Gender | NS | ||
| Male | 20 (80%) | 68 (66%) | |
| Female | 5 (20%) | 35 (34%) | |
| Age: range(mean)1 | 35-78 (60.5) | 25-84 (61.2) | NS |
| Site of tumor | NS | ||
| Body and Cardia | 8 (32%) | 21 (20%) | |
| Antrum | 17 (68%) | 82 (80%) | |
| LN metastasis | NS | ||
| Absent | 7 (28%) | 43 (41%) | |
| Present | 18 (72%) | 60 (59%) | |
| Histological type | < 0.05 | ||
| Diffuse | 18 (72%) | 41 (40%) | |
| Intestinal | 7 (28%) | 62 (60%) | |
| Lymphoid stroma | < 0.05 | ||
| Minimal/mild | 6 (24%) | 71 (69%) | |
| Moderate/intense | 19 (76%) | 32 (31%) |
- Citation: Begnami MD, Montagnini AL, Vettore AL, Nonogaki S, Brait M, Simoes-Sato AY, Seixas AQA, Soares FA. Differential expression of apoptosis related proteins and nitric oxide synthases in Epstein Barr associated gastric carcinomas. World J Gastroenterol 2006; 12(31): 4959-4965
- URL: https://www.wjgnet.com/1007-9327/full/v12/i31/4959.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i31.4959